ABINGDON HEALTH PLC

United Kingdom

Factory icon Manufacturer/ Producer

ABINGDON HEALTH PLC
Web icon

Product catalogue preview

United Kingdom

Abingdon Health offers tailored lateral flow assay development to customers working in the healthcare, veterinary, food and agriculture sectors. At Abingdon Health we take lateral flow immunoassays through a comprehensive development process from concept through to routine manufacture under our ISO 13485 and working to Good Manufacturing Practice quality management system. We have implemented a dedicated team of lateral flow assay specialists who focus on ensuring costs not only coincide with development plans. But, also the team also manages the utilisation of quality materials during development. Meaning when assay specifications are finalised for routine manufacture, costs will allow for an acceptable return on investment. To learn more about our step-by-step development process please contact us..

Request for a quote

United Kingdom

Abingdon Health offers fixed-cost, automated lateral flow manufacturing (works to GMP and ISO certified) with the capacity to manufacture millions of rapid tests per month. Working with customers across multiple sectors, Abingdon Health can tailor manufacturing specific to assay and customer requirements. Our experience, established supply chain and streamlined processes and procedures, coupled with the use of state-of-the-art automated lateral flow manufacturing equipment, contribute to the output of high volume batches in accordance with schedules and budget expectations.

Request for a quote

United Kingdom

Abingdon Health’s PCRD nucleic acid lateral flow immunoassays (NALFIA) are for use alongside isothermal amplification techniques such as LAMP or RPA. Either in a customised or standard format these rapid tests are ideal for the detection of nucleic acids for point of care molecular diagnostics. PCRD Nucleic acid lateral flow immunoassays are qualitative rapid assays designed to detect amplicons labelled with DIG/Biotin and/or FITC (or FAM)/Biotin, with the addition of a control line. Also, PCRD is a rapid, safe and sensitive alternative to ethidium bromide staining of agarose gels. Contact us to learn more about our product

Request for a quote

United Kingdom

AppDx, a customisable Smartphone lateral flow rapid test reader suitable for integration with existing assays or tests requiring development. AppDx combines flexible and connective mobile phone technology to provide a rapid analytical testing solution in any testing location enabling rapid decision making. The intuitive software is suitable for both Apple and Android phones removing the need for separate development for different mobile technologies.

Request for a quote

We are experts and believe that the field of diagnostics is changing with testing increasingly moving away from traditional lab-based testing alone. We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the ability of decision makers to deploy a more rapid response to results. We at Abingdon Health are committed and honest in all that we do. We value the quality and contribution of all, priding ourselves on building long-lasting and trusting partnerships – because by working transparently with customers, partners and colleagues, we are better together. With an exceptional pedigree in developing and manufacturing rapid tests Abingdon Health are expert in responding to our customers varied needs with specific and customisable solutions. Our mission: To improve life by making rapid results accessible to all. By providing the best lateral flow rapid test solutions, we believe we can support the increase in access to diagnostics across many industries and locations throughout the world. Faster access to results allows for rapid decision making and solutions. This ability has a significant role to play in improving life in so many ways.

Latest company news

Antibody testing could today be playing a vital role

Antibody testing could today be playing a vital role

Latest project ・ 15 Jul 2021 read more Open In New icon

Lockdown-easing in the UK comes with caution with officials urging the use of NHS COVID passes. With the UK Prime Minister and the Chief Executive of UK Health Security Agency alluding to immunity status and antibody testing as important considerations for managing risks, Abingdon Health can see challenges in the UK’s COVID pass system which currently doesn't include neutralising IgG antibody testing. In this article we discuss why antibody tests can fill the gap in antigen test and vaccine only COVID strategies. Confirming the presence of SARS-CoV-2 IgG anti-spike antibodies, which neutralise the virus’ ability to penetrate and infect human cells, is powerful for interpreting an individual’s and a population’s immunity status

Domain icon Manufacturer/ Producer

ABINGDON HEALTH PLC

York Biotech Campus, Sand Hutton

YO41 1LZ York - United Kingdom

Contact

Company info

Key figures

  • Company headcount
    201 – 500

Organisation

  • Year established
    2008
  • pages.epage-home.site-status
    Registered office
  • Main activity
    Manufacturer/ Producer

Business info

Trading areas

  • Check Circle Outline icon International

Delivery areas

Activities of ABINGDON HEALTH PLC

  • Biotechnologies
  • lateral flow assay development
  • lateral flow manufacturing
  • rapid diagnostic products
  • lateral flow reader customisation
Office Building Outline icon
A page for your business
Can you see this? Your potential clients will too. Join us now so you too can be visible on europages

Request for quotes

Create one request and get multiple quotes form verified suppliers.

  • Only relevant suppliers
  • Data privacy compliant
  • 100% free